4/A

FORM 4/A SUBMISSION

Company: AMICUS THERAPEUTICS, INC.
Filed: January 6, 2020
Period of Report: January 2, 2020
Accession Number: 0001209191-20-002155

View Document ↗ View on SEC.gov ↗